Truncations and deletions in NF1 activate RAS and its downstream pathways RAF/MEK/ERK and PI3K/AKT [49, 50], both of which are prominent drivers of breast cancer metastasis. This evidence concerns the gene MAP2K7 and breast carcinoma.